A significant part of CLL diagnosis is determining a few critical features which will drive your treatment choices.
CLL usually affects older people. The average age at diagnosis is about 70 years old. It is rare for CLL to occur in people under age 40, and it is even more rare in children. Because it is a disease that develops slowly, many people live for years without symptoms. That’s is also why it is hard to screen for CLL, and doctors have to use a variety of blood tests to confirm diagnosis.
Whether you require treatment for CLL will depend on your blood count, and how quickly the disease is growing. In this series, leading doctors explain how they monitor CLL and the different types of blood cancer.
Breaking Down the Categories of Blood Cancer
Tests That Can Inform the Prognosis of CLL
Monitoring CLL After Initial Diagnosis
A patient’s IGHV mutation status is a key factor in CLL prognosis. Doctors looking for a patient’s IGHV mutation status are looking at the age of the cell that allowed CLL to grow.